Screening CTC rarely finds extracolonic findings among asymptomatic patients, but many are clinically significant.
Extracolonic findings detected during CT colonography (CTC) screening of asymptomatic patients are not common, but when found, they are often clinically significant, according to a study published in the American Journal of Roentgenology.
Researchers from the University of Wisconsin School of Medicine and Public Health in Madison sought to analyze the incidence and outcome of unsuspected significant extracolonic findings in the CT Colonography Reporting and Data System (C-RADS), classified as E4 findings, among patients who were undergoing CTC screening.
A total of 7,952 patients (3,675 men and 4,277 women), mean age of 56.7, participated in the study that took place between April 1, 2004 and June 30, 2012. All patients were undergoing screening for the first time. Potentially significant findings were retrospectively reviewed with additional analysis of follow-up of between two and 10 years and ultimate clinical outcome.
The results showed that 202 of the patients (2.5%) had a potentially significant (C-RADS category E4) extracolonic finding, but none had multiple E4 findings. Of these patients, 113 (56%) were recommended for further imaging and 89 (44%) for clinical follow-up. No patients had multiple category E4 findings. Of 180 patients (22 patients were lost to follow-up), 123 patients (68%) were found to have clinically significant disease; 42 (23%) and 57 patients (32%) with abdominal aortic or other visceral artery aneurysms requiring treatment or surveillance.
Most commonly involved organs and systems:
“Potentially significant extracolonic findings in asymptomatic adults at screening CTC are uncommon (2 to 3 percent of cases),” the researchers wrote. “However, most of these findings (68%) will prove to be clinically significant, including a number of malignancies and aneurysms requiring treatment or surveillance.”
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
AMA Approves Category III CPT Codes for AI-Enabled Perivascular Fat Analysis from CT Scans
April 9th 2025Going into effect in 2026, the new CPT codes may facilitate increased adoption of the CaRi-Heart software for detecting coronary inflammation from computed tomography scans pending FDA clearance of the technology.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.